The shadow above your cheekbone is lost depth, and most patients need 0.5 to 1 mL per side. Juvéderm® Voluma® XC carries a US temple indication in adults over 21. Restylane® Lyft and Sculptra® do not, so placing either in the temple is an off-label use.
Book a consultationWhy a temple hollows
Temple filler is hyaluronic acid gel placed deep on the bone of the temporal fossa. Most need 0.5 to 1 mL per side, holding 12 to 18 months. Juvéderm® Voluma® XC holds a US indication for temple hollowing in adults over 21; use of any other hyaluronic acid gel in the temple is off-label.
Most people meet this hollow in a photograph. Three tissues thin at once: the superficial and deep temporal fat pads, the temporalis muscle and the lateral orbital rim. Gel replaces the depth, deep in the temporal fossa, the basin above the cheekbone. Juvéderm® Voluma® XC carries a US indication for temple hollowing in adults over 21, so the temple is on-label for that gel, while the other products named on this page hold no temple indication and placing them there is off-label.
What changes is the shadow, not the brow. The temporal crest and superficial temporal artery are marked on skin first. Gel goes deep on bone, or subdermally through a blunt cannula.
| Option | Material | Where it sits | Result appears | Typical duration | Reversible with hyaluronidase |
|---|---|---|---|---|---|
| Juvéderm® Voluma® XC | Hyaluronic acid, VYCROSS® crosslinked, with lidocaine | Deep, on the bone of the temporal fossa. Temple use is on-label for this gel | Same day, judged at two weeks | Typically 12 to 18 months | Yes |
| Restylane® Lyft | Hyaluronic acid, NASHA™ crosslinked, with lidocaine | Deep, on bone. Temple use is off-label | Same day, judged at two weeks | Typically 9 to 12 months | Yes |
| Sculptra® | Poly-L-lactic acid, a collagen stimulator | Subcutaneous, spread across the hollow. Temple use is off-label | Gradually, over 3 to 6 months | Typically about 2 years after a full series | No |
These options differ in material, plane, duration and reversibility. Ranges come from product labeling and from what is observed in practice. Of the options listed, only Juvéderm® Voluma® XC holds a US temple indication; the others are used off-label here.
Juvéderm® Voluma® XC — Hyaluronic acid crosslinked with VYCROSS® technology, supplied with lidocaine. Highly cohesive, so it holds projection in a region that moves very little. FDA-approved for cheek and chin augmentation and for temple hollowing in adults over 21. Reversible with hyaluronidase.
Restylane® Lyft — Hyaluronic acid crosslinked with NASHA™ technology, supplied with lidocaine. Firmer and more particulate in the hand than the VYCROSS® gels. FDA-approved for midface contour deficiencies, nasolabial folds and the dorsal hands; use in the temple is off-label. Reversible with hyaluronidase.
Sculptra® — Poly-L-lactic acid, a collagen stimulator rather than a filler. Stimulates the patient's own collagen over three to six months across a series of sessions. Use in the temple is off-label, and it cannot be reversed.
Hyaluronidase — An enzyme that breaks down hyaluronic acid. Its use to dissolve dermal filler is off-label. It does not affect Sculptra® or any non-hyaluronic product.
Standardized photographs at fixed distance and lighting, then palpation of the crest and rim under overhead light.
Your anatomy is drawn on skin first: the temporal crest, the hairline, the superficial temporal artery.
Deep deposits on bone, aspirating before each one. A blunt cannula where the loss is shallow.
Repeat photography, a symmetry check, and a small addition only if it is asked for.
Topical anesthetic is offered, and the gel contains lidocaine. Most people feel pressure, not pain. Swelling shows for two to five days.
A change shows the same day, but give it two weeks before you judge it. Temple filler typically holds 12 to 18 months.
Most people describe pressure rather than pain. The gel contains lidocaine, topical anesthetic is offered, and the injection takes seconds per side. A dull ache at the bone is common and brief. Tenderness lasts a day or two.
Most patients need 0.5 to 1 mL per side, so one syringe often treats both temples. Deeper hollowing occasionally takes more, staged across two visits. Your first appointment is under-corrected on purpose; more is added at the review.
Temple filler typically lasts 12 to 18 months. Hyaluronic acid breaks down faster where muscle works against it, and the temple barely moves. Your own interval depends on product, volume, age and metabolic rate.
Yes, the temple carries real vascular risk. Gel entering a vessel can block the blood supply it feeds, causing skin breakdown or, rarely, vision loss. Vessels are mapped on skin, gel is delivered slowly at low pressure, and hyaluronidase is on site.
No: width is a dose decision, not a property of the gel. Temple filler restores the flat plane, not width beyond it, so a corrected temple reads less gaunt. That is why the first pass is conservative.
Yes, if the product is hyaluronic acid. Juvéderm® Voluma® XC and Restylane® Lyft can both be broken down with hyaluronidase, usually within 24 to 48 hours. Sculptra® cannot be dissolved, because it prompts your own collagen rather than sitting in the tissue.
The cost depends on your treatment plan. Call (614) 425-1633 for current pricing and ask what consultation, treatment, and follow-up charges apply.
Three to seven days, and not for everyone. Temple bruising can drift down to the upper eyelid, because blood tracks along tissue planes. Book at least two weeks before anything you cannot be bruised for.
Not necessarily, and not at the same visit. Cheek support changes how the upper face reads, so a hollow temple can look proportionate once the midface is addressed. The decision then comes from a photograph.
Yes for one of the three gels used here, and off-label for the other two. Juvéderm® Voluma® XC carries a US indication from the FDA for temple hollowing in adults over 21, so in that product the temple is on-label. Restylane® Lyft and Sculptra® hold no temple indication, so placing either one there is an off-label use: the product itself is FDA-approved, but the FDA has not reviewed that particular placement. Off-label use is legal, common in medicine, and left to provider judgement. The product and the indication it holds are named at consultation before you consent.
Rouge Aesthetics is a medical aesthetics practice. This page is general information, not medical advice, and not a substitute for an in-person evaluation. Treatment requires a consultation and a medical eligibility review, and treatment is not provided where it is not indicated.
Individual results vary. Durations on this page are ranges observed in practice and in product labeling, not a promise of a specific result. Nothing described here is a cure, and no outcome is guaranteed.
Juvéderm® Voluma® XC holds a United States indication for temple hollowing in adults over 21. The other products named on this page hold no temple indication, so placing them there is an off-label use of an FDA-approved product. Off-label use is legal and common in medicine, and the product and the indication it holds are named at consultation before you consent.
They show one patient's outcome and do not predict yours.
Juvéderm®, Voluma® and VYCROSS® are registered trademarks of Allergan Aesthetics, an AbbVie company. Restylane®, NASHA™ and Sculptra® are registered trademarks of Galderma. Rouge Aesthetics is an independent practice and is not affiliated with, sponsored by or endorsed by those companies.
Rouge Aesthetics · 101 Mill Street, Suite 210, Gahanna, OH 43230 · (614) 425-1633
Individual results vary. This website provides general information and does not replace an individual consultation.